DoubleLine ETF Adviser LP

Mutual Fund

Position in INCY — Incyte Corp

CIK 1959989 Tampa, FL

Position in INCY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$206,541

New position

Shares Held

1,822

first reported quarter

Ownership

0.001%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#653

of 849 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

DoubleLine ETF Adviser LP holds $2,688,568 across 4 Biotechnology names. INCY ranks #4 (7.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,949	$1,464,856
2	REGN	Regeneron Pharmaceuticals, Inc.	1,209	$753,859
3	MRNA	Moderna, Inc.	3,760	$263,312
4	INCY	Incyte Corp This page	1,822	$206,541

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$206,541	1,822	—	Shares	Sole	2026-08-14
No filing history on record for this holder in this stock.